A
Overview
APDerm Management is a physician-led dermatology group in New England offering medical, surgical, and cosmetic dermatology. It runs a network of clinics with centralized management and an in-house dermatopathology lab, allowing clinicians to focus on patient care. Services include medical dermatology, pediatric dermatology, Mohs surgery, and cosmetic treatments such as laser therapy and injectable fillers. The company aims to provide accessible, high-quality care to patients of all ages and to expand its footprint through strategic growth with Waud Capital Partners.
Work here?Claim your company
Simplify's take
What believers are saying
- APDerm acquired Dermatology Professionals in March 2026, adding Rhode Island and North Attleboro.
- APDerm opened Canton in 2026 and announced Somerville, pushing access toward 25 locations.
- APDerm’s updated site lists six brands and 69 clinicians, showing continuing operational scale.
What critics are saying
- Qilin claimed an August 2025 APDerm breach, exposing patient and financial records.
- APDerm’s nine-year Waud hold raises exit pressure and sponsor fatigue heading into 2027.
- Dermatology consolidation is brutal; Schweiger and regional PE buyers can poach clinicians and practices.
What makes APDerm Management unique
- APDerm spans medical, surgical, cosmetic, pediatric, and Mohs dermatology across New England.
- Waud Capital backed APDerm since September 2017, supporting acquisitions and de novo expansion.
- APDerm runs physician-led local brands with centralized management and an in-house dermatopathology lab.
Help us improve and share your feedback! Did you find this helpful?